CRC CSCs express CD44v6, a variant isoform of CD44, which acts as a coreceptor for MET to activate the EMT program and promote colorectal cancer metastasis and is associated with poor prognosis in CRC patients [18, 19]. Here, CD44 is linked to colorectal carcinoma.